TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2022 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO...

Related Keywords

Paris ,France General ,France ,Australia ,Melbourne ,Victoria ,Canada ,Texas ,United States ,University Of Texas ,Jordan ,Kirk Coleman ,Bradley Gardiner ,John Koleng ,Michael Okunewitch ,Dale Christensen ,Bill Williams ,Corey Davis ,Daniel Carlson ,Donald Owens ,Jonathan Aschoff ,Malcolm Fairbairn ,Company Participants ,Nasdaq ,Tw Research Group ,International Journal Of Pharmaceutics ,Members Of The Congressional Appropriations Committee ,Product Development ,Maxim Group ,Tff Pharmaceuticals Inc ,Lung Transplant Congress ,Biopharm International ,Clinical Development ,Pharmaceuticals Second Quarter ,Human Services ,International Congress On Lung Transplantation ,University Of Texas At Austin ,Exchange Commission ,Conference Call August ,Second Quarter ,Glenn Mattes ,Chief Financial Officer ,Chris Cano ,Risk Factors ,Thin Film Freezing ,Thin Film ,Improved Formulations ,Enable Stable Delivery ,Film Freezing ,International Journal ,Best Paper Award ,Voriconazole Inhalation Powder ,Tacrolimus Inhalation Powder ,Torreya Partners ,Royal Alfred Hospital ,Compassionate Use Study ,International Congress ,Lung Transplantation ,Inhaled Niclosamide ,Niclosamide Phase ,Niclosamide Inhalation Powder ,Glass House ,Congressional Appropriations Committee ,Compassionate Use ,Thanks Glenn ,